-
公开(公告)号:US20130053470A1
公开(公告)日:2013-02-28
申请号:US13529708
申请日:2012-06-21
CPC分类号: A61L33/0023 , A61L27/34 , A61L29/085 , A61L29/14 , A61L29/16 , A61L31/10 , A61L31/14 , A61L31/16 , A61L33/064 , C07B2200/11 , C07F9/062 , C07F9/08 , C07F9/091 , C07F9/106 , C07F9/32 , C07F9/3205 , C07F9/36 , C07F9/40 , C07F9/4078 , C07F9/65742 , C08F30/02 , C08F122/02 , C08F130/02 , C08F220/18 , C08F220/28 , C08F222/02 , C08F230/02 , C08F2220/1825 , C08F2220/281 , C08F2220/285 , C09D133/14 , G02B1/043 , C08L33/26 , C08L33/10 , C08L33/12
摘要: New ampholyte biomaterial compounds containing ampholyte moieties are synthesized and integrated into polymeric assemblies to provide hydrophilic polymers exhibiting improved biocompatibility, haemocompatibility, hydrophilicity non-thrombogenicity, anti-bacterial ability, and mechanical strength, as well as suitability as a drug delivery platform.
摘要翻译: 合成含有两性电解质部分的新的两性电解生物材料化合物并整合到聚合物组件中以提供表现出改进的生物相容性,血液相容性,亲水性,非血栓形成性,抗细菌能力和机械强度以及作为药物递送平台的适用性的亲水性聚合物。
-
公开(公告)号:US20090253733A1
公开(公告)日:2009-10-08
申请号:US12061416
申请日:2008-04-02
IPC分类号: A61K31/439 , C07D498/18 , C12P17/18
CPC分类号: C07D498/18
摘要: Certain embodiments include carbonate esters of rapamycin at position 42 that are synthesized by a lipase catalyzed regio-specific process. These compounds or a pharmaceutically acceptable salt thereof are useful in the treatment of organ and tissue transplant rejection, autoimmune disease, proliferative disorder, restenosis, cancer, or microbial infection.
摘要翻译: 某些实施方案包括通过脂肪酶催化的区域特异性方法合成的位置42的雷帕霉素的碳酸酯。 这些化合物或其药学上可接受的盐可用于治疗器官和组织移植排斥,自身免疫疾病,增殖性疾病,再狭窄,癌症或微生物感染。
-
公开(公告)号:US09567357B2
公开(公告)日:2017-02-14
申请号:US13529708
申请日:2012-06-21
IPC分类号: C07F9/40 , C08F130/02 , C07F9/10 , C08F222/02 , A61L27/34 , A61L31/10 , C07F9/6574 , A61L29/08 , A61L29/14 , A61L29/16 , A61L31/14 , A61L31/16 , A61L33/00 , A61L33/06 , C08F230/02 , C07F9/06 , C07F9/08 , C07F9/32 , C07F9/36 , C08F122/02 , C08F30/02
CPC分类号: A61L33/0023 , A61L27/34 , A61L29/085 , A61L29/14 , A61L29/16 , A61L31/10 , A61L31/14 , A61L31/16 , A61L33/064 , C07B2200/11 , C07F9/062 , C07F9/08 , C07F9/091 , C07F9/106 , C07F9/32 , C07F9/3205 , C07F9/36 , C07F9/40 , C07F9/4078 , C07F9/65742 , C08F30/02 , C08F122/02 , C08F130/02 , C08F220/18 , C08F220/28 , C08F222/02 , C08F230/02 , C08F2220/1825 , C08F2220/281 , C08F2220/285 , C09D133/14 , G02B1/043 , C08L33/26 , C08L33/10 , C08L33/12
摘要: New ampholyte biomaterial compounds containing ampholyte moieties are synthesized and integrated into polymeric assemblies to provide hydrophilic polymers exhibiting improved biocompatibility, haemocompatibility, hydrophilicity non-thrombogenicity, anti-bacterial ability, and mechanical strength, as well as suitability as a drug delivery platform.
摘要翻译: 合成含有两性电解质部分的新的两性电解生物材料化合物并整合到聚合物组件中以提供表现出改进的生物相容性,血液相容性,亲水性,非血栓形成性,抗细菌能力和机械强度以及作为药物递送平台的适用性的亲水性聚合物。
-
-